Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Royal Orchid Hotels Ltd Call Transcript 2018

Oct 30, 2018

60890_rns_2018-10-30_e9fee783-e412-4ef6-add8-19887f65bcdf.pdf

Call Transcript

Open in viewer

Opens in your device viewer

Date: October 30, 2018

To, The Manager, Listing Compliance, Department of Corporate Services, BSE Limited, Floor 25, P. J. Towers, Dalal Street, Mumbai – 400 001 BSE Scrip Code: 532699 To, The Manager, Listing Compliance, Department of Corporate Services, National Stock Exchange of India Limited, Exchange Plaza, Plot no. C/1, G Block Bandra Kurla Complex, Bandra (E) Mumbai – 400 051 NSE Scrip Symbol: ROHLTD

Dear Sir/Madam,

Sub: Concall Invitation to all Analysts

Please find enclosed herewith concall invitation to all Analysts to discuss Q2&H1FY19 results via conference call on Thursday, November 01, 2018 at 03:30PM

This is for the information and records of the exchanges.

Thanking you

Yours sincerely,

For ROYAL ORCHID HOTELS LIMITED

RANABIR SANYAL Digitally signed by RANABIR SANYAL DN: c=IN, o=Personal, postalCode=400709, st=Maharashtra, 2.5.4.20=c8601e66135639ed0c31fce880c3f3a1 d6d626b4dd44c25263433344a0232d55, serialNumber=a17048868a4b5b1ddef858038e 3ed72e3eaf4cc1ee3da699ee1aa34db350b316, cn=RANABIR SANYAL

Date: 2018.10.30 10:25:55 +05'30'

RANABIR SANYAL COMPANY SECRETARY & COMPLIANCE OFFICER

Encl: as above

Mr. Chander K. Baljee Managing Director

Cordially invites all the Analysts to discuss Q2&H1FY19 results via conference call on Thursday, November 01, 2018 at 03:30PM (IST)

Participants: Mr. Chander K. Baljee Managing Director

&

Mr. Amit Jaiswal Chief Financial Officer

Conference Call Dial-in Numbers:
Universal Access Number +91 22 6280 1102
+91 22 7115 8003
Local Access Number +91-7045671221
International Toll Free
Hong Kong 800964448
Singapore 8001012045
UK 08081011573
USA 18667462133

RSVP

Sanjay Punjabi/Chintan Kotak

Adfactors PR – Investor Relations

E: [email protected]/[email protected]

T: +91 9821080084/9920865113